AU Patent

AU2011210326B2 — Sorafenib dimethyl sulphoxide solvate

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2014-10-09 · 12y expired

What this patent protects

The present invention provides dimethyl sulphoxide solvate of 4-(4-{3-[4-chloro- 3-(trifluoromethyl)phenyl]ureido }phenoxy)-N

USPTO Abstract

The present invention provides dimethyl sulphoxide solvate of 4-(4-{3-[4-chloro- 3-(trifluoromethyl)phenyl]ureido }phenoxy)-N

Drugs covered by this patent

Patent Metadata

Patent number
AU2011210326B2
Jurisdiction
AU
Classification
—
Expires
2014-10-09
Drug substance claim
No
Drug product claim
No
Assignee
Sun Pharmaceutical Industries Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.